Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial
NCT07421869Recruiting
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jun 2024
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levothyroxine sodium in hypothyroidism, sponsored by Seoul National University Bundang Hospital. Primary endpoint: Proportion of participants who maintain discontinuation of levothyroxine for at least 6 months. Started Jun 2024; status: recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT07421869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07421869.